Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nutritional boost may speed muscle recovery in seniors after exercise

NCT ID NCT06205537

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a combination of nutritional ingredients can help healthy older adults (ages 60–75) recover muscle strength and reduce soreness after a short, intense exercise session. Thirty participants were randomly assigned to receive either the nutrient blend or a placebo, and researchers measured leg strength, fatigue, and muscle soreness. The goal was to see if these nutrients could support faster recovery and better muscle health in aging adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2024

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult participant, male and female (≥60 and ≤75 years of age) * Subject is ambulatory * Body mass index (BMI) \>18.5 but \<30 kg/m2 * Subject agrees to refrain from starting an exercise program throughout the trial * Has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), and applicable privacy regulation authorization prior to any participation in the study * Willingness to follow the protocol as described, including consumption of study product per the protocol, and completing any forms/questionnaires needed throughout the study Exclusion Criteria: * Subject reports having type 1 or type 2 diabetes * Subject reports having undergone major surgery that might affect the outcomes * Has stated presence of partial or full lower artificial limb * Is unable to participate in an exercise protocol * Habitually engages in strenuous exercise, duration of 1 hour or longer, 3 or more times per week * Subjects has received systemic corticosteroid treatment in the last 3 months * Subject reports recent oral antibiotic use * Subject reports of current active malignant disease, except basal or squamous cell skin carcinoma or carcinoma in situ of the uterine cervix * Subject reports of significant cardiovascular event within 6 months prior to study entry or history of congestive heart failure * Subject reports of end-stage organ failure or is post-organ transplant * Subject reports of current or history of renal disease or severe gastroparesis * Subject reports of current diagnosed hepatic disease * Subject reports of history of GI disease that could impact digestion or absorption of the study product * Subject reports a history of autoimmune or connective tissue diseases that may affect muscle. * Subject reports clotting or bleeding disorders. * Subject reports a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis A, B or C, or HIV. * Subjects reports an eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures * Subject reports having statin-induced myopathy at time of screening. * Subject reports taking certain dietary supplements, oral nutritional supplements or high protein nutritional supplements, or medications, that could profoundly affect muscle metabolism. Exceptions for multi-vitamin/mineral supplement and inhaled steroids for asthma, topical or optical steroids. Those users who can stop using such products for ≥4 weeks before baseline visit and agree to refrain from taking them over the study period need not be excluded. * Subject cannot refrain from using specific oils in their home cooked meals over the course of the study. * Has an allergy or intolerance to any ingredient in the study product. * Participates in another study that has not been approved as a concomitant study by Abbott Nutrition. * Subject has participated in another research study in the last 3 months that involved an inconvenience allowance or biosampling (including \>50ml blood or any tissue samples).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Exercise induced muscle damage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Nottingham

    Derby, DE22 3DT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.